The VEGF, IGF-1, and TGF-β markers can be key biomarkers related to fibroid development and shrinkage after UAE treatment [16,17,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32,33,34]. This evidence concerns the gene IGF1 and leiomyoma.